Essential hypertension (EH) is characterised by increased thrombotic tendency and impaired fibrinolytic activity. However, exercise-induced changes in coagulation and fibrinolysis have not yet ...

Newer fibrinolytic agents are equivalent but not superior to older fibrin-specific agents. 20,21 Aggressive antiplatelet therapy with glycoprotein IIb/IIIa inhibitors improves the rate of patency ...

Dennis T. Ko, M.D. However, a significant proportion of STEMI patients will "fail" to reperfuse following fibrinolytic therapy; indeed, normal coronary blood flow (TIMI flow grade 3) is achieved ...

Fibrinolytic therapy, also known as thrombolytic therapy, is used to lyse acute blood clots by activating plasminogen, resulting in the formation of plasmin, which cleaves the fibrin cross-links ...

Archive The Nature of the Fibrinolytic-Enzyme Defect in Hyaline-Membrane Disease Author: Jack Lieberman, M.D. Author Info & Affiliations Published August 24, 1961 N Engl J Med 1961;265: 363 - 369 ...

Fibrinolytic Therapy for Myocardial Infarction With and Without Coronary Revascularization J. Willis Hurst, MD Disclosures December 04, 2002 0 Introduction ...

In Paul Armstrong's review article on fibrinolytic therapy for acute ST-segment elevation myocardial infarction, the fibrinolytic or thrombolytic treatment recommended for the case presented is not ...

Fibrinolytic biomarkers for identifying patients at risk of severe COVID-19 Researchers identify associations between proteins involved in fibrinolysis and the development of acute respiratory ...

Fibrin-Specific Agents Come Out on Top For the network meta-analysis, the investigators included 40 randomized controlled trials with a total of 128,071 patients. The studies, published between 1986 ...

A fibrinolytic agent is given intraventricularly with the aim of lysing thrombi in the ventricles. After 8 hours, ventricular irrigation is started by infusing artificial CSF through the frontal ...

Current evidence on the efficacy and safety of drainage, irrigation and fibrinolytic therapy (DRIFT) for post-haemorrhagic hydrocephalus in preterm infants is inadequate in quantity. Therefore, this ...